Filing Details

Accession Number:
0001626176-15-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-15 11:23:49
Reporting Period:
2015-01-13
Filing Date:
2015-01-15
Accepted Time:
2015-01-15 11:23:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369786 Sagent Pharmaceuticals Inc. SGNT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230193 Morgan Stanley Investment Management Inc 1221 Avenue Of Americas
New York NY 10020
No No Yes No
1230207 Morgan Stanley Aip Gp Lp One Tower Bridge
100 Front Street Suite 1100
West Conshohocken PA 19428
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-01-13 50,000 $25.49 3,681,292 No 4 S Indirect See Footnote
Common Stock Disposition 2015-01-14 50,000 $25.53 3,631,292 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Represents shares of Common Stock owned by certain funds (each, a "Fund" and collectively, the "Funds") and certain separtely managed accounts managed by the undersigned.
  2. The shares reported are held of record by Stormlaunch & Co., Sailershell & Co., Stormbay & Co., Stormstar & Co., Weyerhaeuser Company Master Retirement Trust, Sailerpier & Co., Factory Mutual Insurance Company and Nuclear Electric Insurance Limited.
  3. The reported securites are held directly by the Funds and certain separately managed accounts managed by each of the reporting persons. Morgan Stanley Investment Management Inc. (MSIM) is the investment manager of one or more of the separately managed accounts and Morgan Stanley AIP GP LP ("AIP") is the investment manager of one or more of the Funds. This form is filed without prejudice to the reporting persons' position that none of the Funds nor any subsidiaries of the reporting persons, nor the reporting persons individually or in aggregate, are required to file beneficial ownership reports under Section 16(a) of the Securities Exchange Act of 1934, and should not be construed or interpreted as a concession or admission that such reports are required.